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33 Abstract
34 A population of kisspeptin neurons located in the hypothalamic arcuate nucleus 
35 (ARN) very likely represent the gonadotrophin-releasing hormone pulse generator 
36 responsible for driving pulsatile luteinizing hormone secretion in mammals.  As such, 
37 it has become important to understand the neural inputs that modulate the activity 
38 of ARN kisspeptin (ARNKISS) neurons. Using a transgenic GCaMP6 mouse model 
39 allowing the intracellular calcium levels (i[Ca2+]) of individual ARNKISS neurons to be 
40 assessed simultaneously, we examined whether the circadian neuropeptides 
41 vasoactive intestinal peptide (VIP) and arginine vasopressin (AVP) modulated the 
42 activity of ARNKISS neurons directly.  To validate this methodology, we initially 
43 evaluated the effects of neurokinin B (NKB) on i[Ca2+] in kisspeptin neurons residing 
44 within the rostral, middle and caudal ARN subregions of adult male and female mice. 
45 All experiments were undertaken in the presence of tetrodotoxin and ionotropic 
46 amino acid antagonists. NKB was found to evoke an abrupt increase in i[Ca2+] in 95-
47 100% of kisspeptin neurons throughout the ARN of both sexes. In marked contrast, 
48 both VIP and AVP were found to primarily activate kisspeptin neurons located in the 
49 caudal ARN of female mice. Whereas 58 and 59% of caudal ARN kisspeptin neurons 
50 responded to AVP and VIP, respectively, in female mice, only 0-8% of kisspeptin 
51 neurons located in other ARN subregions responded in females and 0-12% of cells in 
52 any subregion in males (p<0.05). These observations demonstrate unexpected sex 
53 differences and marked heterogeneity in functional neuropeptide receptor 
54 expression amongst ARNKISS neurons organized on a rostro-caudal basis.  The 
55 functional significance of this unexpected influence of VIP and AVP on ARNKISS 
56 neurons remains to be established. 
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57 Introduction
58 The pulsatile release of luteinizing hormone (LH) is critical for fertility.  Adult males 
59 exhibit an LH pulse approximately every 3h while females show variable LH pulse 
60 rates ranging from a pulse every hour in the follicular phase to one every 3h in the 
61 luteal phase of the cycle (1).  However, a variety of internal and external factors can 
62 drive LH pulse frequency outside this normal range to suppress fertility. For example, 
63 the high LH pulse frequency of females with polycystic ovary syndrome and slow 
64 pulsatility observed in hypothalamic amenorrhea are often associated with infertility 
65 (2-4). 
66 Studies examining a range of mammalian species over recent years have indicated 
67 that kisspeptin neurons co-expressing neurokinin B and dynorphin (KNDy neurons) 
68 located in the hypothalamic arcuate nucleus are responsible for generating the 
69 pulsatile pattern of gonadotropin-releasing hormone (GnRH) release that drives 
70 pulsatile LH secretion (1, 5).  As such, the arcuate nucleus KNDy or kisspeptin 
71 (ARNKISS) neurons have become a focal point for investigators wanting to understand 
72 how different physiological and pathophysiological factors influence LH pulse 
73 frequency (1, 6, 7). 
74 Although the definition and role of circadian inputs to the preoptic population of 
75 kisspeptin neurons has received much attention (8, 9), no information exists 
76 regarding the potential circadian regulation of the ARNKISS neurons.  Studies in 
77 humans have identified sleep-wake variations in LH pulse frequency (10-12) raising 
78 the possibility that some form of circadian input may also be directed at the ARNKISS 
79 neurons. To begin to investigate this possibility, we have examined whether ARNKISS 
80 neurons in the mouse express functional receptors for arginine vasopressin (AVP) 
81 and vasoactive intestinal peptide (VIP), the two major neuropeptidergic outputs from 
82 the suprachiasmatic nucleus (SCN). Studies in rats and mice have identified receptors 
83 for both of these neuropeptides in the arcuate nucleus (13-15) and SCN neurons are 
84 known to project to and modulate the activity of ARN neurons in the rat (16, 17). 
85 However, we note that many neural populations expressing VIP and AVP are also 
86 found outside the SCN and may conceivably have a role in regulating LH secretion.
87
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88 To examine the potential effects of AVP and VIP, we have established a transgenic 
89 GCaMP6 calcium imaging approach that enables the effects of neurotransmitters on 
90 adult ARNKISS neurons to be assessed in the acute brain slice.  To ensure that we 
91 measure direct effects of these neuropeptides on kisspeptin neurons, intracellular 
92 calcium concentrations ([Ca2+]i) were assessed in the presence of amino acid receptor 
93 antagonists and tetrodotoxin (TTX).  
94
95 Materials and Methods
96 Experimental animals
97 Mice were generated by crossing Kiss1-Cre+/- (18) and homozygous floxed GCaMP6f 
98 (Ai95(RCL-GCaMP6f)-D)(19) lines to generate mixed background 129S6Sv/Ev 
99 C57BL6 Kiss1-Cre::GCaMP6f-lox-STOP-lox (Kiss1::GCaMP6) mice. Mice were group-
100 housed under conditions of controlled temperature (22±20C) and lighting (12-hour 
101 light/12-hour dark cycle (lights on at 6:00h and off at 18:00h) with ad libitum access 
102 to food and water. The University of Otago Animal Ethics Committee approved all 
103 animal experimental protocols.
104
105 Immunohistochemistry
106 Four adult female Kiss1::GCaMP6f mice were ovariectomized under Halothane 
107 anesthesia and 3-weeks later anesthetized and perfused through the heart with 4% 
108 paraformaldehyde, phosphate-buffered saline for free-floating dual 
109 immunofluorescence histochemistry as reported previously (20, 21). Mice were 
110 ovariectomized so as to increase the level of kisspeptin peptide in ARN neurons to 
111 improve immunohistochemical detection. Primary antisera raised against GFP 
112 (rabbit 1:5,000, Invitrogen; RRID:AB_221570) and kisspeptin (sheep 1:1,000, AC053 
113 gift of Alain Caraty, Nouzilly, France)(22) were used to increase the GCaMP6 signal 
114 and detect kisspeptin, respectively. Secondary antisera were biotinylated donkey 
115 anti-sheep immunoglobulins (1:200, Jackson ImmunoResearch Labs, PA) followed by 
116 streptavidin-568 (1:200, Molecular Probes), and donkey anti-rabbit-488 (1:200, 
117 Jackson), respectively. Dual-fluorescence images were captured on a NikonA1+ 
Page 4 of 23Journal of Neuroendocrinology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
5
118 inverted confocal microscope. Two sections at each of the rostral, middle and caudal 
119 levels of the ARN were analyzed in each mouse by counting the total number of cells 
120 that expressed GFP (GCaMP6) and/or kisspeptin.
121
122 Calcium imaging
123 The i[Ca2+] of multiple ARNKISS neurons was monitored simultaneously in acute brain 
124 slices using a methodology previously established for the preoptic kisspeptin 
125 neurons (23). Coronal brain slices (250m-thick) containing the rostral, middle and 
126 caudal regions of the ARN were prepared from adult male and diestrous-stage female 
127 Kiss1::GCaMP6f mice between 10:00-11:00h (N=4 for each sex, region and 
128 neuropeptide) and constantly perfused (1mL/min) with 300C, 95%O2/5%CO2 
129 equilibrated, artificial cerebrospinal fluid (aCSF) comprised of (mM) NaCl 120, KCl 3, 
130 NaHCO3 26, NaH2PO4 1, CaCl2 2.5, MgCl2 1.2 and glucose 10. To ensure that only direct 
131 neuropeptide responses were recorded from ARNKISS neurons, the aCSF contained 
132 TTX (0.5 μM) and the ionotropic GABAA and glutamate receptor antagonists 
133 picrotoxin (100 μM), CNQX (10 μM), and AP5 (40 μM) at all times (all sourced from 
134 Tocris Biosciences). Slices were placed under an upright Olympus BX51W1 
135 microscope and multiple individual cells in a plane of focus visualized through a 40x 
136 immersion objective using a xenon arc light source (300 W, filtered by a GFP filter 
137 cube (excitation 470-490 nm, Chroma)) and a DG-4 shutter (Sutter Instruments) 
138 providing 100ms duration light at 2Hz. Epifluorescence (495 nm long pass and 
139 emission 500-520 nm) was collected using a Hamamatsu ORCA-ER digital CCD 
140 camera.  
141 The effects of neuropeptides on ARNKISS neuron GCaMP6f fluorescence were assessed 
142 by measuring basal fluorescence over a 4 min period and then adding the test 
143 neuropeptide to the aCSF for a two-min period before switching back to aCSF only. 
144 Regions of interest over individual, non-overlapping, and in-focus fluorescent somata 
145 were selected and analyzed using ImageJ software and custom R scripts. Individual 
146 cells were considered to have responded if they exhibited an increase in fluorescence 
147 during the 2-min test period that was greater than their mean baseline level + 2 
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148 standard deviations (SD) derived from basal recordings. To accommodate for the 
149 gradual decline in fluorescence levels that occurs over the test period, the 
150 fluorescence levels over the first 4-min basal period were divided into the first (b1) 
151 and second (b2) two-minute basal recording periods and an adjusted baseline (F) for 
152 the 2-min stimulation period set at = b2-(b1-b2). For visualizing data, values are 
153 presented as relative fluorescence changes using  where F is the ∆FF = Ft ― FF ∗ 100
154 adjusted baseline and Ft is the fluorescence measured. 
155 To assess effects of neuropeptides on ARNKISS neuron located at different rostro-
156 caudal levels of the ARN, four rostral, four middle and four caudal slices from four 
157 separate mice were tested with each neuropeptide. The different rostrocaudal levels 
158 were determined by the distinctive topography of kisspeptin neurons in each area 
159 and the shape of the median eminence (Fig.1). Each slice received only one test.  
160 Results are reported as number of cells examined (n) and numbers of slices or mice 
161 (N). The effects of neurokinin B (NKB, 50nM), AVP (300nM) and VIP (1M) (Tocris 
162 Bioscience) were examined.  Prior studies in the laboratory have shown that these 
163 concentrations are effective in activating the firing of kisspeptin, GnRH and other 
164 neurons in acute brain slices (23-25). Statistical analysis comparing between sexes 
165 and ARN subregions was undertaken with two-way ANOVA and post-hoc Tukey tests.
166
167 Results
168 Expression of GCaMP6 in arcuate nucleus kisspeptin neurons
169 The distribution of GCaMP6-expressing cells throughout the rostro-caudal extent of 
170 the ARN in Kiss1::GCaMP6f mice (Fig.1A) was identical to that reported for kisspeptin 
171 neurons (21) with the largest numbers of cells detected in the caudal ARN (Table).  
172 Dual-label immunofluorescence demonstrated that 88-95% of GCaMP6 cells 
173 expressed kisspeptin and virtually all (99%) kisspeptin neurons contained GCaMP6 
174 (Fig.1B-D, Table).  
175
176 GCaMP6 calcium imaging
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177 The GCaMP6 imaging enabled the fluorescence levels of 8-25 ARNKISS neurons to be 
178 evaluated simultaneously in each brain slice.  Initial control experiments in slices 
179 from four diestrous female mice showed that 53 of the 54 recorded cells (N=4 slices) 
180 exhibited a stable baseline level of fluorescence that gradually declined over time 
181 (Fig.2). Only one of the 54 cells was found to show spontaneous fluctuations (Fig.2).
182
183 NKB activates all kisspeptin neurons in the ARN of males and females
184 To test the validity of this preparation, we first examined the effects of NKB as this 
185 neuropeptide has been reported to have direct stimulatory effects on the firing of 
186 nearly all ARNKISS neurons in male mice (24, 26, 27). Exposure to 50nM NKB was 
187 found to evoke an increase in fluorescence levels in essentially all GCaMP6-
188 expressing cells located throughout the ARN (Fig.3A-C). Responses could be abrupt 
189 or take over 1 min to occur with baseline levels typically restored to normal within 4-
190 5 min of the response (Fig.3C). In four diestrous Kiss1::GCaMP6f female mice, 37 
191 rostral, 100 middle, and 65 caudal cells were tested in four brain slices from each 
192 region with 100% of cells exhibiting a change in fluorescence signal that was > basal 
193 + 2SD. The same result was found for male mice (N=4) with 28/28 rostral, 75/79 
194 (95%) middle and 84/87 (97%) caudal cells responding to NKB (Fig.3D). Basal 
195 fluorescence signals in males were the same as those observed for females with only 
196 occasional evidence of spontaneous calcium transients.  No significant differences 
197 were detected between any regions or sexes (p>0.05, Two-way ANOVA).
198
199 VIP activates caudal arcuate kisspeptin neurons in a sexually dimorphic manner.
200 The administration of 1M VIP was found to have no effects upon GCaMP6 
201 fluorescence in 35 kisspeptin neurons (N=4) located in the rostral-aspect of the ARN 
202 in female Kiss1::GCaMP6f mice (Fig.4A).  While the middle ARN (N=4) was similar 
203 with only 2/58 (3%) cells responding, 46/80 (58%) kisspeptin neurons in the caudal 
204 ARN (N=4) were activated by VIP (Fig.4A,B; p<0.05 compared with other subregions, 
205 Two-way ANOVA, post-hoc Tukey’s tests).  These responses could take up to 2 min to 
206 initiate and typically exhibited a fluctuating profile before returning to baseline up to 
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207 10 min later (Fig.4B).  Although a relationship between the basal level of fluorescence 
208 and the magnitude of any response existed, responding cells could not be predicted 
209 by their basal level of fluorescence.  In male Kiss1::GCaMP6f mice, no cells in the 
210 rostral (n=32, N=4) or middle aspects of the ARN (n=71, N=4) responded to VIP with 
211 only 3/57 (6%, N=4) kisspeptin neurons in the caudal stimulated (p<0.05 compared 
212 to females, Two-way ANOVA, post-hoc Tukey’s tests; Fig. 4C). 
213
214 AVP activates caudal arcuate kisspeptin neurons in a sexually dimorphic manner.
215 Exposure to 300nM AVP had minimal effects on fluorescence levels in kisspeptin 
216 neurons located in the rostral (2/34 cell responded, 6%, N=4) and middle (5/66 cells, 
217 8%, N=4) aspects of the ARN but increased intracellular calcium levels in 46 of 78 
218 (59%, N=4) cells located in the caudal ARN (Fig.5A; p<0.05 compared with other 
219 subregions, Two-way ANOVA, post-hoc Tukey’s tests).  Responses evoked by AVP 
220 were typically immediate upon entry of AVP into the bath but short-lived, sometimes 
221 terminating during the application period (Fig.5B). In male Kiss1::GCaMP6f mice, 4-
222 12% of kisspeptin neurons responded throughout the rostro-caudal extent of the 
223 ARN; 1/24 rostral (4%), 5/67 middle (8%) and 10/81 caudal (12%)(N=4 each, 
224 Fig.5C). The numbers of kisspeptin neurons responding to AVP were significantly 
225 different in the caudal ARN of females compared to other subregions and males 
226 (p<0.05 compared to females, Two-way ANOVA, post-hoc Tukey’s tests; Fig. 5C).
227
228
229 Discussion 
230
231 We report here the unexpected observation that kisspeptin neurons located at 
232 different rostro-caudal locations within the ARN can express different functional 
233 neuropeptide receptors and, further, that this is sexually dimorphic. Whereas all 
234 ARNKISS neurons in both males and females express tachykinin receptors activated by 
235 NKB, the kisspeptin neurons activated by AVP and VIP are located primarily within 
236 the caudal ARN and exhibit a marked female-dominant sex difference.  These 
237 observations highlight the functional heterogeneity and striking sexually dimorphic 
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238 nature of the ARNKISS neuron population and, further, indicate that this may be 
239 organized in a rostro-caudal topographic manner.
240
241 The Kiss1::GCaMP6f mouse line was found to provide high fidelity targeting of 
242 GCaMP6 to the ARNKISS neuron population with essentially 100% of kisspeptin 
243 neurons expressing GCAMP6 and these cells representing 88-95% of all GCaMP6 
244 neurons located in the ARN. As such, this mouse line provides a good model 
245 preparation for examining the direct responses of ex-vivo ARNKISS neurons to putative 
246 neurotransmitters and neuropepitdes. Nevertheless, the approach has caveats, 
247 principally being that inhibitory effects of transmitters, or receptor activation that 
248 does not directly or indirectly modulate i[Ca2+], will not be revealed.  Thus, false 
249 negatives may occur but positive responses will be indicative of the presence of 
250 cognate receptors for the transmitter examined.
251
252 Prior electrophysiological brain slice studies have shown that 90-100% of ARNKISS 
253 neurons are activated by NKB or tachykinin receptor agonists in male mice (24, 26, 
254 27).  In good agreement, we find that essentially 100% of ARNKISS neurons in intact 
255 male mice respond directly to NKB with elevated i[Ca2+] and now extend this to 
256 demonstrate that this is also the case in diestrous female mice. Prior studies using 
257 dual-label in situ hybridization have reported that 75-100% of ARNKISS neurons 
258 located in the middle aspects of the ARN express Tacr3 transcripts in female mice (27, 
259 28).  By targeting recordings to the rostral, middle and caudal aspects of the ARN we 
260 are able to demonstrate remarkable consistency in the functional expression of NKB-
261 activated receptors by ARNKISS neurons in both males and females.  As a sub-
262 population of ARNKISS neurons will be the GnRH pulse generator, these observations 
263 are in good agreement with in vivo data showing that intracerebroventricular 
264 administration of senktide, an NK3R agonist, activates LH secretion in both intact 
265 male and diestrous-stage female mice (29). 
266
267 In striking contrast to the effects of NKB, both AVP and VIP exerted subregion- and 
268 sex-dependent effects on ARNKISS neuron i[Ca2+].  Whereas 58% of caudal ARNKISS 
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269 neurons responded to VIP in females only 6% were activated in male, and essentially 
270 no cells were stimulated in the rostral or middle regions of the ARN in either sex. 
271 Similarly, 58% of caudal ARNKISS neurons were activated by AVP compared with only 
272 4 -12% of neurons in other regions or in males. This indicates that female caudal 
273 ARNKISS neurons preferentially express functional receptors for VIP and AVP.  
274 Although not addressed in this study, it is possible that changes in ARNKISS neuron 
275 sensitivity to AVP and VIP may occur with postnatal development or across the 
276 estrous cycle in females.
277
278 Similar numbers of caudal ARNKISS neurons are activated by AVP and VIP in female 
279 but they evoke very different profiles of changing  i[Ca2+]. The molecular identities of 
280 the receptors activated are not known although VIP at 1M concentrations would be 
281 expected to activate both type 1 (VPAC1) and type 2 (VPAC2) VIP receptors in 
282 addition to the pituitary adenylate cyclase-activating peptide (PACAP) receptor (30).  
283 Recent studies have shown that PACAP neurons located in the premammillary 
284 nucleus project to ARNKISS neurons and can directly activate a sub-population of 
285 caudal ARN neurons in female mice (31). Hence, it is possible that PACAP is the 
286 endogenous ligand for VIP receptors expressed by ARNKISS neurons. Recent 
287 transcriptome-based cell sorting strategies failed to identify any AVP or VIP/PACAP 
288 receptor transcripts in pools of ARNKISS neurons from young female or mixed 
289 male/female mice (32, 33).  Given the sex-dependent and highly regionalised nature 
290 of AVP and VIP receptor expression revealed here, future transcriptomic studies of 
291 ARNKISS neuron will need to take potential subregion and sex differences into 
292 consideration. 
293
294 The sex- and region-specific nature of AVP and VIP effects identified here would not 
295 support the concept of a generalized direct circadian regulation of ARNKISS neurons 
296 by these neuropeptides. Studies have found day-night differences in LH pulse 
297 frequency in both human males and females (10-12) although their dependence on 
298 circadian cues, as opposed to environmental influences such as sleep and stress, has 
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299 been challenged (34).  Further, while studies in rodents have identified circadian-like 
300 changes in LH secretion in peripubertal females, it has remained unclear whether this 
301 was related to pulse or surge modes of LH secretion (35).  Hence, it is possible that 
302 there is no direct or substantial circadian modulation of the different ARNKISS neuron 
303 sub-populations. Instead, VIP/PACAP and AVP inputs to ARNKISS neurons may 
304 originate from neural populations located outside the suprachiasmatic nucleus, as 
305 has recently been demonstrated for PACAP neurons of the premammilary nucleus 
306 (31).  Interestingly, preliminary viral retrograde tracing data indicate that 
307 vasopressin neurons in the supraoptic nucleus project to ARNKISS neurons (Yeo & 
308 Colledge, unpublished).
309  
310 The function of neuropeptidergic inputs directed at caudal ARNKISS neurons in the 
311 female can only be speculated upon at present. Sex differences in ARNKISS morphology 
312 and function have been documented (20, 36) but the extent to which this depends on 
313 sexually differentiated inputs is unknown. Further, the functions of AVP/VIP-
314 sensitive ARNKISS neurons are unknown and may even be unrelated to the regulation 
315 of GnRH neurons. Indeed, tract tracing studies have shown that caudal ARNKISS 
316 neurons project to multiple limbic brain region in the mouse (37).  On the other hand, 
317 recent optogenetic studies have indicated that the ARNKISS neuron pulse generator 
318 may be located in the middle-caudal aspects of the nucleus (21) although no further 
319 features or markers of this population have been identified as yet. One intriguing 
320 speculation is that SCN inputs to ARNKISS neurons may modulate the LH surge. 
321 Although there is little evidence for the ARN to be involved in the timing of the LH 
322 surge (38), recent studies have suggested that the ARNKISS neurons may be involved 
323 in regulating the amplitude of the LH surge (39, 40), potentially through direct 
324 projections to preoptic area kisspeptin neurons (41).
325
326 In summary, these studies reveal marked sex- and subregion-specific effects of two 
327 neuropeptides on ARNKISS neurons. These observations reinforce the concept of 
328 functional heterogeneity amongst the ARNKISS neuron population. Alongside other 
329 evidence (21, 37), it seems that this heterogeneity may, in part, be organized on a 
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330 rostro-caudal basis within the ARN of the mouse.  In contrast, we find that the 
331 response of ARNKISS neurons to NKB is extremely uniform impacting upon essentially 
332 all kisspeptin neurons throughout the nucleus in both males and females. The 
333 functional relevance of this heterogeneity with respect to pulse generation as well as 
334 other functions of the ARNKISS neuron population awaits elucidation.  More 
335 specifically, the surprising observation of sexually dimorphic and region-specific AVP 
336 and VIP signaling within the ARNKISS neuron population raises intriguing questions as 
337 to the roles of these neuropeptides within the ARN.
338
339
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479 Figure legends 
480
481 Figure 1. Distribution of GCaMP6 in arcuate nucleus (ARN). A. Images from the same 
482 adult female mouse showing the GFP-immunofluorescence (GCaMP6) in the rostral, 
483 middle and caudal levels of the ARN. B-D, confocal images showing dual fluorescence 
484 for GFP- (B) and kisspeptin- (C) immunofluorescence, and with the overlapping 
485 signals represented in D.
486
487 Figure 2.  Baseline GCaMP6 fluorescence levels in arcuate kisspeptin neurons. A. Raw 
488 fluorescence levels of eight ARN kisspeptin neurons located in a middle arcuate 
489 nucleus brain slice over 12 min. B. Higher resolution change in fluorescence levels of 
490 5 of these cells showing the one cell (cell 3) that exhibited spontaneous fluctuations.
491
492 Figure 3. NKB activates essentially all kisspeptin neurons in both male and female mice. 
493 A. Single frame photograph of GCaMP6 fluorescence in the middle ARN of a slice being 
494 imaged. The five cells shown in C are labelled.  B. Raw fluorescence recordings from 
495 21 kisspeptin neurons in that brain slice showing their response to a 2-min 
496 application of 50nM NKB (grey bar) in the presence of TTX and amino acid receptor 
497 antagonists.  C. Higher resolution change in fluorescence levels from the five cells 
498 depicted in A. Colors are the same as in B. D. Histogram showing the percentage of 
499 kisspeptin neurons in the rostral, middle and caudal aspects of the ARN that 
500 responded to NKB in male and female mice (N=4, each). 
501
502 Figure 4. VIP preferentially activates caudal ARN kisspeptin neurons in female mice. A. 
503 Raw fluorescence traces from the rostral, middle and caudal aspects of the ARN from 
504 the same diestrous female Kiss1::GCaMP6f mouse. The two-min 1M VIP exposure 
505 period is indicated by the grey bar and each colored line represents a different cell. B. 
506 Higher resolution changes in fluorescence showing the response profiles of six caudal 
507 kisspeptin neurons to VIP. C. Histogram showing the percentage of kisspeptin 
508 neurons in the rostral, middle and caudal aspects of the ARN responding to VIP in 
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509 male and female mice (N=4 each) * p<0.05 compared to all other groups, Two-way 
510 ANOVA with post-hoc Tukey tests.
511
512 Figure 5. AVP preferentially activates caudal ARN kisspeptin neurons in female mice. 
513 A. Raw fluorescence traces from the rostral, middle and caudal aspects of the ARN 
514 from diestrous female Kiss1::GCaMP6f mouse. The two-min 300nM AVP exposure 
515 period is indicated by the grey bar and each colored line represents a different cell. 
516 Note the orange cell in the caudal traces that was discarded from analysis as it 
517 exhibited a spontaneous fluctuation in fluorescence prior to the test with AVP. B. 
518 Higher resolution change in fluorescence images showing the AVP response profiles 
519 of five of the caudal kisspeptin neurons shown in A. C. Histogram showing the 
520 percentage of kisspeptin neurons in the rostral, middle and caudal aspects of the ARN 
521 responding to AVP in male and female mice (N=4 each). * p<0.05 compared to all 
522 other groups, Two-way ANOVA with post-hoc Tukey tests.
523
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524 Table nos. Kiss neurons / hemi-section % GCaMP6 cells +ve for kisspeptin % kisspeptin cells +ve for GCaMP6rostral ARN 37±14 88±7% 99±1%middle ARN 60±7 94±1% 99±1%caudal ARN 68±8 95±2% 99±1%
525
526 Table showing the numbers of kisspeptin-immunoreactive neurons detected in the 
527 three subregions of the ARN and their levels of co-expression with GCaMP6. N = 4 
528 ovariectomized female mice.
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Figure 1. Distribution of GCaMP6 in arcuate nucleus (ARN). A. Images from the same adult female mouse 
showing the GFP-immunofluorescence (GCaMP6) in the rostral, middle and caudal levels of the ARN. B-D, 
confocal images showing dual fluorescence for GFP- (B) and kisspeptin- (C) immunofluorescence, and with 
the overlapping signals represented in D.
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Figure 2.  Baseline GCaMP6 fluorescence levels in arcuate kisspeptin neurons. A. Raw fluorescence levels of 
eight ARN kisspeptin neurons located in a middle arcuate nucleus brain slice over 12 min. B. Higher 
resolution change in fluorescence levels of 5 of these cells showing the one cell (cell 3) that exhibited 
spontaneous fluctuations.
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Figure 3. NKB activates essentially all kisspeptin neurons in both male and female mice. A. Single frame 
photograph of GCaMP6 fluorescence in the middle ARN of a slice being imaged. The five cells shown in C are 
labelled.  B. Raw fluorescence recordings from 21 kisspeptin neurons in that brain slice showing their 
response to a 2-min application of 50nM NKB (grey bar) in the presence of TTX and amino acid receptor 
antagonists.  C. Higher resolution change in fluorescence levels from the five cells depicted in A. Colors are 
the same as in B. D. Histogram showing the percentage of kisspeptin neurons in the rostral, middle and 
caudal aspects of the ARN that responded to NKB in male and female mice (N=4, each). 
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Figure 4. VIP preferentially activates caudal ARN kisspeptin neurons in female mice. A. Raw fluorescence 
traces from the rostral, middle and caudal aspects of the ARN from the same diestrous female 
Kiss1::GCaMP6f mouse. The two-min 1M VIP exposure period is indicated by the grey bar and each 
colored line represents a different cell. B. Higher resolution changes in fluorescence showing the response 
profiles of six caudal kisspeptin neurons to VIP. C. Histogram showing the percentage of kisspeptin neurons 
in the rostral, middle and caudal aspects of the ARN responding to VIP in male and female mice (N=4 each) 
* p<0.05 compared to all other groups, Two-way ANOVA with post-hoc Tukey tests. 
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Figure 5. AVP preferentially activates caudal ARN kisspeptin neurons in female mice. A. Raw fluorescence 
traces from the rostral, middle and caudal aspects of the ARN from diestrous female Kiss1::GCaMP6f mouse. 
The two-min 300nM AVP exposure period is indicated by the grey bar and each colored line represents a 
different cell. Note the orange cell in the caudal traces that was discarded from analysis as it exhibited a 
spontaneous fluctuation in fluorescence prior to the test with AVP. B. Higher resolution change in 
fluorescence images showing the AVP response profiles of five of the caudal kisspeptin neurons shown in A. 
C. Histogram showing the percentage of kisspeptin neurons in the rostral, middle and caudal aspects of the 
ARN responding to AVP in male and female mice (N=4 each). * p<0.05 compared to all other groups, Two-
way ANOVA with post-hoc Tukey tests. 
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